Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.
Sustained aviraemia despite anti-retroviral therapy non-adherence in male children following in utero hiv transmission.
Targeting Viral Transcription for HIV Cure Strategies.
Exploring the HIV-1 Rev Recognition Element (RRE)-Rev Inhibitory Capacity and Antiretroviral Action of Benfluron Analogs.
Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.
Understanding the neurological implications of acute and long COVID using brain organoids.
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.